SHR-1020

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-1020, covering 2021-05-25 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer [Phase 2]

See pricing